These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1991038)

  • 1. Avidin acylation prevents the complement-dependent lysis of avidin-carrying erythrocytes.
    Muzykantov VR; Smirnov MD; Samokhin GP
    Biochem J; 1991 Jan; 273(Pt 2)(Pt 2):393-7. PubMed ID: 1991038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avidin-induced lysis of biotinylated erythrocytes by homologous complement via the alternative pathway depends on avidin's ability of multipoint binding with biotinylated membrane.
    Muzykantov VR; Smirnov MD; Samokhin GP
    Biochim Biophys Acta; 1992 Jun; 1107(1):119-25. PubMed ID: 1616915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tannin-mediated attachment of avidin provides complement-resistant immunoerythrocytes that can be lysed in the presence of activator of complement.
    Muzykantov VR; Smirnov MD; Zaltzman AB; Samokhin GP
    Anal Biochem; 1993 Feb; 208(2):338-42. PubMed ID: 8452230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptavidin-induced lysis of homologous biotinylated erythrocytes. Evidence against the key role of the avidin charge in complement activation via the alternative pathway.
    Muzykantov VR; Smirnov MD; Samokhin GP
    FEBS Lett; 1991 Mar; 280(1):112-4. PubMed ID: 2009954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avidin attachment to red blood cells via a phospholipid derivative of biotin provides complement-resistant immunoerythrocytes.
    Muzykantov VR; Smirnov MD; Klibanov AL
    J Immunol Methods; 1993 Feb; 158(2):183-90. PubMed ID: 8429223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tannin-mediated attachment of avidin to erythrocytes does not cause their lysis by complement].
    Muzykantov VR; Smirnov MD; Zal'tsman AB; Samokhin GP
    Biokhimiia; 1993 Jul; 58(7):1027-32. PubMed ID: 8364121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avidin attachment to biotinylated erythrocytes induces homologous lysis via the alternative pathway of complement.
    Muzykantov VR; Smirnov MD; Samokhin GP
    Blood; 1991 Nov; 78(10):2611-8. PubMed ID: 1824256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast lysis by complement and uptake by liver of avidin-carrying biotinylated erythrocytes.
    Muzykantov VR; Seregina N; Smirnov MD
    Int J Artif Organs; 1992 Oct; 15(10):622-7. PubMed ID: 1428212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target-sensitive immunoerythrocytes: interaction of biotinylated red blood cells with immobilized avidin induces their lysis by complement.
    Muzykantov VR; Zaltsman AB; Smirnov MD; Samokhin GP; Morgan BP
    Biochim Biophys Acta; 1996 Mar; 1279(2):137-43. PubMed ID: 8603079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor.
    Zaltzman AB; Van den Berg CW; Muzykantov VR; Morgan BP
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):651-6. PubMed ID: 7537958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avidin attachment to biotinylated amino groups of the erythrocyte membrane eliminates homologous restriction of both classical and alternative pathways of the complement.
    Muzykantov VR; Smirnov MD; Klibanov AL
    FEBS Lett; 1993 Mar; 318(2):108-12. PubMed ID: 8440366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of avidin-carrying red blood cells with nucleated cells.
    Muzykantov VR; Zalzman AB; Fuki IV; Smirnov MD; Samokhin GP; Romanov YA
    Biochim Biophys Acta; 1993 Nov; 1179(2):148-56. PubMed ID: 8218357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the complement-mediated elimination of red blood cells modified with biotin and streptavidin.
    Muzykantov VR; Murciano JC; Taylor RP; Atochina EN; Herraez A
    Anal Biochem; 1996 Oct; 241(1):109-19. PubMed ID: 8921172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the human classical complement pathway by a mouse monoclonal hybrid IgG1-2a monovalent anti-TNP antibody bound to TNP-conjugated cells.
    Couderc J; Kazatchkine MD; Ventura M; Duc HT; Maillet F; Thobie N; Liacopoulos P
    J Immunol; 1985 Jan; 134(1):486-91. PubMed ID: 3917282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential susceptibility of haemolysin-sensitized erythrocytes to complement-mediated cytotoxicity: a biological manifestation of the relationship between antibody availability and complement fixation.
    Bakács T; Ringwald G; Kimber I
    J Clin Lab Immunol; 1989 Oct; 30(2):61-7. PubMed ID: 2641530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Human Erythrocyte-based Haemolysis Assay for the Evaluation of Human Complement Activity.
    King RAN; Climacosa FMM; Santos BMM; Caoili SEC
    Altern Lab Anim; 2020 May; 48(3):127-135. PubMed ID: 33006498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attachment of biotinylated antibody to red blood cells: antigen-binding capacity of immunoerythrocytes and their susceptibility to lysis by complement.
    Muzykantov VR; Taylor RP
    Anal Biochem; 1994 Nov; 223(1):142-8. PubMed ID: 7695090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ability to sensitize host cells for destruction by autologous complement is a general property of lipoteichoic acid.
    Weinreb BD; Shockman GD; Beachey EH; Swift AJ; Winkelstein JA
    Infect Immun; 1986 Nov; 54(2):494-9. PubMed ID: 3533782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability to activate the alternative complement pathway acquired by human and guinea-pig erythrocytes after contact with influenza virus.
    Lambré C; Thibon M
    Ann Immunol (Paris); 1980; 131C(2):213-21. PubMed ID: 7416718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.